EUCTR2007-003548-32-LT进行中（未招募）不适用
A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Control
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •?Patient has type 2 diabetes mellitus (T2DM).
- •?Patient has moderate or severe renal insufficiency as indicated by a creatinine clearance <50 mL/min and is not likely to require dialysis throughout the duration of the study.
- •?Patient is = 30 years of age on day of signing informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •?Patient is on dialysis or is likely to need dialysis during the study.
- •?Patient has type 1 diabetes mellitus or a history of ketoacidosis.
- •?Patient has been diagnosed with a significant cardiovascular disorder (e.g. MI or unstable angina) or has had a cardiovascular procedure (e.g. CABG or PTCA) within 3 months of signing informed consent.
- •?Patient has new or worsening signs or symptoms of congestive heart failure within 3 months of signing informed consent.
研究者
相似试验
进行中（未招募）
1 期
A Blinded Study to Evaluate Higher Versus Standard Adalimumab Doses for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal UlceratioMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's diseaseEUCTR2013-001746-33-BEAbbVie Deutschland GmbH & Co. KG514
进行中（未招募）
1 期
A Blinded Study to Evaluate Higher Versus Standard Adalimumab doses for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal UlceratioMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's diseaseEUCTR2013-001746-33-ATAbbVie Deutschland GmbH & Co. KG500
已完成
3 期
Efficacy and Safety Study of Alogliptin Compared to Glipizide in Elderly DiabeticsCTRI/2009/091/000123Takeda Global Research & Development Centre (Europe) Ltd (TGRD)61 AldwychLondon WC2B 4AE United Kingdom
进行中（未招募）
1 期
A Blinded Study to Evaluate Higher Versus Standard Adalimumab doses for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal UlceratioCrohn's diseaseMedDRA version: 19.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2013-001746-33-CZAbbVie Deutschland GmbH & Co. KG600
进行中（未招募）
1 期
A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK-0431 Monotherapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control - MK-0431 Monotherapy Study in Patients with Type 2 DMMedDRA version: 7.0Level: LLTClassification code 10045242Type 2 Diabetes MellitusEUCTR2004-000313-19-HUMerck & Co., Inc.18